Ginza Houou (Phoenix) Clinic

Guided by a singular, unwavering purpose — “We do everything we can for the patient’s will to live” — Ginza Phoenix Clinic stands as Tokyo’s foremost private clinic dedicated to advanced cancer immunotherapy and regenerative stem cell medicine. This is not an aesthetic clinic or a wellness spa; it is a precision oncology centre where cutting-edge cellular science meets deeply compassionate, patient-centred care.

Under the visionary leadership of Director Dr. Hisashi Nagai — M.D., Ph.D. from The University of Tokyo and Visiting Associate Professor at Tokai University — the clinic harnesses the extraordinary power of the human immune system to fight cancer in ways that conventional oncology alone cannot achieve. Dr. Nagai’s ground-breaking research on macrophage-mediated circulation control and tumour immunology forms the scientific bedrock for the clinic’s proprietary cancer immune cell therapy protocols, including a pending-patent NKT cell culture technology (Patent Application No. 特願2025-95087).

The clinic’s treatment arsenal spans the full spectrum of modern cancer immunotherapy: the flagship α-GalCer + WT1 Dendritic Cell Vaccine combination — arguably the most sophisticated DC therapy available in Japan — Super Highly-Activated NK Cell Therapy using a unique 3-week culture protocol for fivefold cell amplification, the pioneering NKT Triple Immune Cell Therapy that simultaneously activates three immune cell types, and immune checkpoint inhibitors (Opdivo, Yervoy) used in synergy with cellular therapies for maximum effect.

For patients facing the most challenging diagnoses, Ginza Phoenix Clinic offers hope, science, and humanity — all in one private, dedicated space.